1. Home
  2. EHTH vs HBIO Comparison

EHTH vs HBIO Comparison

Compare EHTH & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eHealth Inc.

EHTH

eHealth Inc.

N/A

Current Price

$0.73

Market Cap

28.5M

Sector

Finance

ML Signal

N/A

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

N/A

Current Price

$7.98

Market Cap

26.5M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
EHTH
HBIO
Founded
1997
1901
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.5M
26.5M
IPO Year
2006
2000

Fundamental Metrics

Financial Performance
Metric
EHTH
HBIO
Price
$0.73
$7.98
Analyst Decision
Hold
Buy
Analyst Count
3
2
Target Price
$3.33
★ $18.00
AVG Volume (30 Days)
★ 352.6K
15.3K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 71.43
N/A
EPS
N/A
★ N/A
Revenue
★ $251,395,000.00
$116,176,000.00
Revenue This Year
N/A
$4.77
Revenue Next Year
$5.60
$8.55
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 45.86
N/A
52 Week Low
$0.75
$0.38
52 Week High
$5.89
$8.40

Technical Indicators

Market Signals
Indicator
EHTH
HBIO
Relative Strength Index (RSI) 23.30 59.14
Support Level N/A $5.84
Resistance Level $1.58 $8.19
Average True Range (ATR) 0.05 0.17
MACD -0.00 -0.07
Stochastic Oscillator 7.57 31.97

Price Performance

Historical Comparison
EHTH
HBIO

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

Share on Social Networks: